A more than two-decade analysis of subcutaneous venom immunotherapy (VIT) in children with Hymenoptera venom allergy showed high safety, with only 0.4% systemic reactions (SRs) from 3739 total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results